CONMED (CNMD) Q1 2024 Earnings
CNMD·Reported April 24, 2024·After market close
CONMED reported Q1 2024 revenue of $311.6M, beat analyst consensus of $306.8M by $4.9M. Diluted EPS came in at $0.79, beat the $0.74 consensus by $0.05.
Revenue
$311.6Mbeat by $4.9M
Consensus: $306.8MDiluted EPS
$0.79beat by $0.05
Consensus: $0.74
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about CONMED's Q1 2024 earnings report.
CONMED (CNMD) reported Q1 2024 earnings on April 24, 2024 after market close.
CONMED reported revenue of $311.6M and diluted EPS of $0.79 for Q1 2024.
Revenue beat the consensus estimate of $306.8M by $4.9M. EPS beat the consensus estimate of $0.74 by $0.05.
You can read the 10-Q periodic report (0000816956-24-000006) directly on SEC EDGAR. The filing index links above go to sec.gov.